Salesforce Earnings Preview: Analysts Reset Outlook

Salesforce earnings show options pricing signaling a large post-earnings move ahead of May 27 Q1 report, prompting traders to hedge AI traction and margins.

May 27, 2026·2 min read
View all news articles
Flat vector of a cloud server with pulsing circuit waves to symbolize Salesforce earnings event risk and options volatility.

KEY TAKEAWAYS

  • Options markets price a large post-earnings move into Salesforce ahead of the May 27 Q1 report.
  • Jefferies models Q1 FY27 revenue growth at 12.5% and cRPO growth at 14.0%.
  • Shares had risen about 2% in recent sessions as traders sought evidence of AI traction and margin durability.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Salesforce, Inc. (CRM) is set to report fiscal first-quarter 2027 (Q1 FY27) results after the close on Wednesday, May 27. Analysts have revised models ahead of the print, while options markets price in a large post-earnings move as traders assess AI product traction and margin durability.

Earnings Timing and Analyst Models

Jefferies projects Salesforce will deliver total revenue growth of 12.5% year-over-year for Q1 FY27, with current remaining performance obligations (cRPO) rising 14.0%. The brokerage’s model implies fiscal 2027 earnings per share (EPS) of $13.14, likely on a non-GAAP basis. This outlook is supported by a Jefferies partner survey showing 55% of respondents finished the quarter at plan and 30% exceeded it, indicating steady demand.

Other analysts maintain generally positive views, with 12-month price targets clustering in the mid-$260s to mid-$270s range. BTIG recently reiterated a Buy rating with a $255 target. No new company filings or investor-relations releases have updated guidance in the past 72 hours.

Investors and analysts are focused on whether Salesforce can stabilize growth in its core cloud applications and platform, sustain double-digit cRPO and revenue expansion, and balance profitability with ongoing AI investment. AI’s impact on product adoption and enterprise spending remains a key theme shaping expectations.

Options Signal Elevated Event Risk

Options pricing implies a sizable post-earnings stock move, reflecting elevated event risk ahead of the report. Salesforce shares rose about 2% in recent sessions as traders sought signs of growth stabilization and clarity on AI monetization and margin durability.

The broader market supported this momentum. On May 27 at 7:44 a.m. ET, Nasdaq-100 futures were up roughly 0.6%, with S&P 500 and Dow futures rising about 0.4%, reflecting an AI-led tech rally ahead of earnings from Salesforce and other major tech companies.

With sell-side models projecting double-digit growth and options markets pricing elevated volatility, the after-close report and management commentary will be decisive for near-term stock direction. Investors will closely watch whether Salesforce can sustain its revenue and cRPO growth while managing AI-driven innovation without eroding margins.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Amazon Corning Fiber-Optic Deal Adds North Carolina Jobs

Amazon Corning Fiber-Optic Deal Adds North Carolina Jobs

Amazon Corning fiber-optic deal expands U.S. manufacturing and adds 1,000 jobs while positioning Corning as a supplier for Amazon's data centers.

Roche Nurix Deal Advances BTK Program

Roche Nurix Deal Advances BTK Program

Roche Nurix deal sets U.S. co-commercialization and outlines near-term clinical catalysts, with material deal economics that matter to biotech investors.

Campbell Q3 Results: Sales Fall, Profit Rises

Campbell Q3 Results: Sales Fall, Profit Rises

Campbell Q3 results showed sales fell on snacks weakness, profit rose and management reaffirmed fiscal 2026 guidance, keeping focus on margins.

Marvell S&P 500 Addition Sparks Premarket Jump

Marvell S&P 500 Addition Sparks Premarket Jump

Marvell S&P 500 inclusion sparked a premarket surge and should prompt index-fund buying, concentrating passive flows and shifting near-term positioning.

Intesa Bid For Monte Dei Paschi Sparks Takeover Fight

Intesa Bid For Monte Dei Paschi Sparks Takeover Fight

Intesa bid for Monte dei Paschi triggers a takeover fight and forces investors to weigh carve-outs, a Generali holding and regulatory approvals.

Eli Lilly Retatrutide Shows Strong Late-Stage Results

Eli Lilly Retatrutide Shows Strong Late-Stage Results

Eli Lilly retatrutide's ADA results reportedly topped GLP-1 rivals; CVS Caremark covering Zepbound widens payer access and boosts the commercial outlook.